Deborah Birx - Dec 21, 2023 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Executive Officer, Director
Signature
/s/ Deborah Birx
Stock symbol
ARMP
Transactions as of
Dec 21, 2023
Transactions value $
$0
Form type
4
Date filed
12/26/2023, 09:53 PM
Previous filing
Jul 19, 2023
Next filing
Mar 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Award $0 +200K $0.00 200K Dec 21, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +200K $0.00 200K Dec 21, 2023 Common Stock 200K $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the Stock Options shall vest on July 10th of each of 2024, 2025, 2026, and 2027.